Eisai launches antiepileptic drug in China

China |  News | 0 Comment | 09 Jan, 2020

Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, for use in adjunctive treatment of partial onset ...Read more

CStone initiates CS1001 trial to treat ESCC in China

China |  News | 0 Comment | 08 Jan, 2020

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as fir...Read more

Innovent and Sirnaomics enter into strategic collaboration

China |  News | 0 Comment | 08 Jan, 2020

China based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic an...Read more

China approves AstraZeneca’s Lokelma to treat hyperkalaemia

China |  News | 0 Comment | 07 Jan, 2020

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the...Read more

Yisheng inks oncology deal with Tavotek

China |  News | 0 Comment | 07 Jan, 2020

China headquartered Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, a...Read more

Antengene Corporation appoints former Celgene China GM John Chin as CBO

China |  News | 0 Comment | 07 Jan, 2020

Antengene Corporation has announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commerci...Read more

I-Mab Biopharma commences pivotal study of TJ202/MOR202 in China

China |  News | 0 Comment | 06 Jan, 2020

I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States and focused on the discovery and development of novel or highly differ...Read more

Leap, BeiGene to develop immunotherapy for gastric cancer

China |  News | 0 Comment | 06 Jan, 2020

US based Leap Therapeutics, Inc. a biotechnology company developing targeted immuno-oncology therapeutics, and China headquartered BeiGene, Ltd., a commercial-stage biopharmaceutical compan...Read more

WuXi STA opens oligonucleotide large-scale manufacturing facility

China |  News | 0 Comment | 03 Jan, 2020

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec  has announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) m...Read more

BeiGene completes acquisition deal with Amgen

China |  News | 0 Comment | 03 Jan, 2020

BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer has ann...Read more

Fountain Medical appoints Ling Zhen as Co-Chairman and CEO

China |  News | 0 Comment | 02 Jan, 2020

China based Fountain Medical Development Limited ("Fountain Medical" or "Company"), a clinical stage CRO dedicated to offering high-quality one-stop services to pharmaceutical and medical d...Read more

CF PharmTech to accelerate respiratory drugs development

China |  News | 0 Comment | 02 Jan, 2020

China based CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million ...Read more

China grants priority review to Luye Pharma's schizophrenia drug

China |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004), an innovative formulation independently developed ...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

China |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This ...Read more

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

China |  News | 0 Comment | 31 Dec, 2019

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences in San Francisco, California at the...Read more

China's Largest Plasmid and Virus Facility from GenScript in Operation

China |  News | 0 Comment | 20 Dec, 2019

The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation on December 18, 2019. It is a milest...Read more

Sinovac receives China's approval for varicella vaccine

China |  News | 0 Comment | 31 Dec, 2019

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medical Products Administration (NMPA) has approved and issued a Product li...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

China |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of m...Read more